Overview
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Description
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids (EPA or DHA) in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Eligibility
Inclusion Criteria:
- DSM-5 diagnosis of ADHD
- Did not have any changes of ADHD treatment (pharmacological/psychological) within 4 weeks of entering the trial.
- SNAP-IV inattention subscale \>=12, or hyperactivity subscale \>=12, or inattention+ hyperactivity subscales \>=24
Exclusion Criteria:
- IQ\<80
- Allergic to omega-3
- Physical disorders: thyroid function, cancer
- Psychiatric comorbidity: SUD, psychotic disorders, bipolar disorder, major depressive disorder